Table 4Critical Appraisal of NICE Clinical Practice Guideline5

DomainAppraisal
Scope and purposeObjectives and clinical questions are defined, but specific patient populations to whom the recommendations apply are unclear.
Stakeholder involvementTarget users of the guideline are defined, guideline development group includes members of relevant professional groups, and patient input has been sought. Recommendations have not been pilot tested among target users.
Rigour of developmentEvidence was gathered using systematic literature review, and selection criteria and methods for recommendation formulation were described. Explicit links have been drawn between evidence and recommendations, guideline was externally peer reviewed, and updating procedures are provided.
Clarity and presentationRecommendations are identifiable, specific, and unambiguous. It was unclear whether additional tools were developed for effective guideline implementation.
ApplicabilityPotential cost implications for, but not organizational barriers to, recommendation application have been considered.
Editorial independenceConflict of interest statements provided for some, but not all, guideline development members. No statement about editorial independence from the funding body.

NICE = National Institute for Clinical Evidence.

From: 5, RESULTS

Cover of Preoperative Skin Antiseptic Preparations and Application Techniques for Preventing Surgical Site Infections: A Systematic Review of the Clinical Evidence and Guidelines
Preoperative Skin Antiseptic Preparations and Application Techniques for Preventing Surgical Site Infections: A Systematic Review of the Clinical Evidence and Guidelines [Internet].
Kamel C, McGahan L, Mierzwinski-Urban M, et al.
Copyright © CADTH (June 2011)

You are permitted to make copies of this document for non-commercial purposes provided it is not modified when reproduced and appropriate credit is given to CADTH.

Links: This document may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third-party sites is governed by the owners’ own terms and conditions set out for such sites. CADTH does not make any guarantee with respect to any information contained on such third-party sites and CADTH is not responsible for any injury, loss, or damage suffered as a result of using such third-party sites.

Industry: The following manufacturers were provided with an opportunity to comment on an earlier version of this report: 3M Canada, AstraZeneca Canada Inc., CareFusion. All comments that were received were considered when preparing the final report.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.